<DOC>
<DOCNO>
EP-0015155
</DOCNO>
<TEXT>
<DATE>
19800903
</DATE>
<IPC-CLASSIFICATIONS>
A61P-9/08 C07D-207/335 <main>C07D-403/06</main> A61P-7/00 A61P-9/00 C07D-403/00 C07D-521/00 C07D-207/32 A61P-7/02 A61P-9/10 C07D-207/00 C07D-403/06 A61P-43/00 A61K-31/415 
</IPC-CLASSIFICATIONS>
<TITLE>
imidazole thromboxane synthetase inhibitors, processes for preparing them, and pharmaceutical compositions containing them.
</TITLE>
<APPLICANT>
pfizergb<sep>pfizer ltdgb<sep>pfizer corporation<sep>pfizer limited<sep>pfizer corporationcalle 15 1/2 avenida santa isabelcolonpa<sep>pfizer limitedramsgate roadsandwich kent ct13 9njgb<sep>pfizer corporation <sep>pfizer limited<sep>
</APPLICANT>
<INVENTOR>
cross peter edward<sep>dickinson roger peter<sep>cross, peter edward<sep>dickinson, roger peter<sep>cross, peter edward21 cherry avenuecanterbury, kentgb<sep>dickinson, roger peter6 kingston closeriver, dover kentgb<sep>cross, peter edward  <sep>dickinson, roger peter<sep>cross, peter edward21 cherry avenuecanterbury, kentgb<sep>dickinson, roger peter6 kingston closeriver, dover kentgb<sep>
</INVENTOR>
<ABSTRACT>
imidazoles of the formula:    wherein r¹ is lower cycloalkyl, lower cycloalkyl-lower alkyl,  lower alkenyl-lower alkyl, lower alkanoyl, phenyl, lower  cycloalkyl-carbonyl, or a group of the formula:    wherein x is hydrogen, carboxy or lower alkoxycarbonyl; y is  hydrogen, lower alkyl, lower alkoxy or halogen; n is an integer  of from 1 to 4; and z is cyano, carboxy or lower alkoxycar­ bonyl; and the pharmaceutically acceptable acid addition  salts thereof.  the compounds selectively inhibit the action of  the thromboxane synthetase enzyme without significantly  inhibiting the action of the prostacyclin synthetase or cyclo­ oxygenase enzymes and are thus useful in the treatment of  thrombosis, ischaemic heart disease, stroke, transient  ischaemic attack, migraine and the vascular complications of  diabetes.  
</ABSTRACT>
</TEXT>
</DOC>
